Author
Bahram Hassanpourfard
-
AI puts the ultrasound probe in more hands as histotripsy reaches a $3.75bn valuation
AI guidance is putting the ultrasound probe in more hands, the major vendors have refreshed their ranges and histotripsy has reached a $3.75bn valuation.
-
NHS prescribing bill set to run about £460m above inflation in 2026, driven by GLP-1s
England’s NHS prescribing bill is on course to finish 2026 well ahead of inflation.
-
FDA approves first heart valve designed to grow with children
The FDA approved the Autus Size-Adjustable Valve, a surgically implanted pulmonary heart valve for paediatric patients with congenital pulmonary valve disease, which it describes as the first heart valve designed to grow with children.
-
FDA approves AbbVie’s first-in-class Parkinson’s pill as pharma deal-making accelerates
The FDA approved AbbVie’s tavapadon, branded Juvmo, for adults with Parkinson’s disease, as deal-making dominated the rest of the week.
-
Apotek Analytics welcomes Dr Oliver Hulson to our advisory board
Dr Oliver Hulson, Consultant Radiologist at Leeds Teaching Hospitals NHS Trust, joins the Apotek Analytics advisory board.
-
Can AI in Gynaecologic Ultrasound Close the Diagnosis Gap in Endometriosis?
Can AI-enhanced ultrasound help close the diagnosis gap in endometriosis? Chiara Tagliavini looks at the evidence so far and the potential ahead.